Carmel, IN, United States of America

Richard James Loncharich

This inventor holds 2 USPTO granted patents. Top assignee: Eli Lilly and Company. Active years: 2001-2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Richard James Loncharich. Retrieved from https://idiyas.com/inventor/richard-james-loncharich

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 23.0

ph-index = 2

Forward Citations = 45(Granted Patents)


Company Filing History:


Years Active: 2001-2004

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Richard James Loncharich

Introduction

Richard James Loncharich is a notable inventor based in Carmel, Indiana. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on tricyclic compounds. With a total of two patents to his name, Loncharich's inventions are aimed at addressing critical medical conditions.

Latest Patents

Loncharich's latest patents focus on a class of novel tricyclics. These compounds are disclosed for their potential use in inhibiting sPLA mediated release of fatty acids. This innovation is particularly relevant for the treatment of conditions such as septic shock. The dual emphasis on the same class of compounds highlights the importance of this research in the medical field.

Career Highlights

Richard James Loncharich is currently associated with Eli Lilly and Company, a leading pharmaceutical firm. His work at Eli Lilly has allowed him to explore and develop groundbreaking solutions in medicine. His contributions are vital in advancing therapeutic options for patients.

Collaborations

Loncharich has collaborated with esteemed colleagues such as Nicholas J Bach and Susan Elizabeth Draheim. These partnerships have fostered a collaborative environment that enhances the innovation process.

Conclusion

Richard James Loncharich's work exemplifies the spirit of innovation in the pharmaceutical industry. His patents and collaborations reflect a commitment to improving medical treatments and patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…